Active Shortage Tablet Cardiovascular
Quinapril · 1,331 days since initial FDA posting
Brand: QUINAPRIL AND HYDROCHLOROTHIAZIDE
FDA lists Quinapril as Active Shortage (Chartwell Molecular Holdings LLC).
Availability on file: Available
Quinapril/Hydrochlorothiazide Tablet: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Quinapril/Hydrochlorothiazide Tablet
- Manufacturer
- Chartwell Molecular Holdings LLC
- Dosage Form
- Tablet
- Presentation
- Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)
- Package NDC
- 62135-669-90
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jan 19, 2023
- Last Updated
- Feb 2, 2026
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Quinapril/Hydrochlorothiazide Shortage Records
Quinapril/Hydrochlorothiazide Tablet
Aurobindo Pharma USA
Tablet
Quinapril/Hydrochlorothiazide Tablet
Aurobindo Pharma USA
Tablet
Quinapril/Hydrochlorothiazide Tablet
Aurobindo Pharma USA
Tablet
Quinapril/Hydrochlorothiazide Tablet
Chartwell Molecular Holdings LLC
Tablet
Quinapril/Hydrochlorothiazide Tablet
Chartwell Molecular Holdings LLC
Tablet